Cargando…
Tacrolimus toxicity due to enzyme inhibition from ritonavir
Tacrolimus is commonly used for immunosuppression in patients following solid organ transplantation. For transplant patients with COVID-19 infection, early treatment is indicated due to the risk of progression to severe disease. However, the first line agent, nirmatrelvir/ritonavir, has multiple dru...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159930/ https://www.ncbi.nlm.nih.gov/pubmed/37173153 http://dx.doi.org/10.1016/j.ajem.2023.04.045 |